Topical anesthetic analgesic therapy using the combination of ropivacaine and dexmedetomidine: hyaluronic acid modified long-acting nanostructured lipid carriers containing a skin penetration enhancer

PURPOSE: Hyaluronic acid-poly(ethylene glycol)-distearoyl phosphoethanolamine (HA-PEG-DSPE) modified and tocopheryl polyethylene glycol 1000 succinate (TPGS) contained nanostructured lipid carriers (NLCs) were prepared loading ropivacaine and dexmedetomidine to improve the topical anesthetic analges...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yongjian, Qiu, Dahai, Liu, Yajun, Chao, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755955/
https://www.ncbi.nlm.nih.gov/pubmed/31571832
http://dx.doi.org/10.2147/DDDT.S211443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755955/
https://www.ncbi.nlm.nih.gov/pubmed/31571832
http://dx.doi.org/10.2147/DDDT.S211443

Ejemplares similares